SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016263
Filing Date
2022-08-10
Accepted
2022-08-10 07:56:51
Documents
43
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcrx-20220630.htm   iXBRL 10-Q 2655694
2 EX-10.1 tcrx-ex10_1.htm EX-10.1 117308
3 EX-31.1 tcrx-ex31_1.htm EX-31.1 28094
4 EX-31.2 tcrx-ex31_2.htm EX-31.2 28370
5 EX-32.1 tcrx-ex32_1.htm EX-32.1 12444
6 EX-32.2 tcrx-ex32_2.htm EX-32.2 12335
7 GRAPHIC img20623631_0.jpg GRAPHIC 1754
8 GRAPHIC img20623631_1.jpg GRAPHIC 3130
  Complete submission text file 0000950170-22-016263.txt   5775081

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcrx-20220630.xsd EX-101.SCH 34845
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcrx-20220630_def.xml EX-101.DEF 169870
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcrx-20220630_lab.xml EX-101.LAB 329649
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcrx-20220630_pre.xml EX-101.PRE 250162
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcrx-20220630_cal.xml EX-101.CAL 27436
37 EXTRACTED XBRL INSTANCE DOCUMENT tcrx-20220630_htm.xml XML 404429
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40603 | Film No.: 221150443
SIC: 2836 Biological Products, (No Diagnostic Substances)